Bal Krishan Saini designated as Senior Management Personnel of Panacea Biotec Pharma

Ruchika Sharma

Bal Krishan Saini designated as Senior Management Personnel of Panacea Biotec Pharma

Written By : Ruchika Sharma Published On 2025-11-14T14:30:59+05:30 | Updated On 14 Nov 2025 2:31 PM IST

New Delhi: Panacea Biotec has announced that Bal Krishan Saini, Senior Vice President - Head Pharma Plant Operations & Corporate Project and Engineering Head has been designated as the Senior Management Personnel of the Company’s material wholly owned subsidiary, Panacea Biotec Pharma Limited.

Bal Krishan Saini has over 30 plus years of extensive experience in Engineering, Projects and Operations and had successfully led site Engineering, project, operations and plant management in USFDA / MHRA / WHO-compliant facilities, particularly in sterile injectable and formulation manufacturing.

He holds a Six Sigma Black Belt, leadership management training from ISB, cGMP training, and advanced degrees including M. Tech and PG Diploma in Environmental Health and Occupational Safety.

Prior to his joining, he was acting as Director (VP) – Operations at Emcure Pharmaceuticals Ltd., leading multiplants sterile and OSD manufacturing facilities, overseeing production, engineering, warehousing, and EHS. He has also held several positions at various companies including Akorn India, Wockhardt Ltd. and Unichem Laboratories Ltd.

Panacea Biotec is a Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals and Vaccines.

Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited. It got publically listed on Indian National Stock Exchanges in September 1995 as Panacea Biotec Ltd. The international pharmaceutical formulations product portfolio includes innovative prescription products in niche therapeutic areas such as Pain, Diabetes & Cardiovascular management, Oncology, Renal Disease, Osteoporosis management and Gastro-intestinal care.

panacea biotecBal Krishan Sainiappointmentpanacea biotec pharma

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751